Truist analyst Asthika Goonewardene downgraded Cargo Therapeutics (CRGX) to Hold from Buy with a $7 price target
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRGX:
- Cargo Therapeutics downgraded to Underweight from Overweight at JPMorgan
- Cargo Therapeutics sinks 75% to $3.23 after study failure, analyst downgrades
- Cargo Therapeutics downgraded to Market Perform from Outperform at William Blair
- Cargo Therapeutics downgraded to Neutral from Overweight at Piper Sandler
- Cargo Therapeutics downgraded to Hold from Buy at Jefferies